OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth [Yahoo! Finance]
Opko Health, Inc. (OPK)
Last opko health, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.opko.com
Company Research
Source: Yahoo! Finance
The optimism surrounding the stock is backed by RAYALDEE's performance and strategic partnerships. However, stiff competition and overdependence on RAYALDEE pose concerns. Shares of this Zacks Rank #2 (Buy) company have declined 4.5% over the past six months compared to the industry's 11.2% gain. The S&P 500 has increased 12.9% in the said time frame. This renowned multinational biopharmaceutical and diagnostics company has a market capitalization of $974.9 million. The company predicts 30% growth for fiscal 2026 and anticipates maintaining its strong performance going forward. OPKO Health's earnings surpassed estimates in two of the trailing four quarters and missed in the other two, the average beat being 58.52%. Image Source: Zacks Investment Research Potential of RAYALDEE : RAYALDEE, OPKO Health's flagship renal therapy in the U.S. market over the past two years, is the first and only FDA-approved treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chro
Show less
Read more
Impact Snapshot
Event Time:
OPK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPK alerts
High impacting Opko Health, Inc. news events
Weekly update
A roundup of the hottest topics
OPK
News
- Is OPKO Health (OPK) Pricing Reflect Its DCF Upside Despite Weak Long Term Returns [Yahoo! Finance]Yahoo! Finance
- 7MM Hyperparathyroidism, Hyperphosphatemia, and Hyperkalemia in Chronic Kidney Disease Market Opportunity Assessment and Forecasts 2024-2034 [Yahoo! Finance]Yahoo! Finance
- AI genome sequencing could transform rare disease diagnosis: GeneDx CEO [FOX Business Network]FOX Business Network
- Is GeneDx Holdings (WGS) Pricing Look Attractive After Mixed Long Term Share Performance [Yahoo! Finance]Yahoo! Finance
- GeneDx Announces GenomeDx Prenatalâ„¢, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care [Yahoo! Finance]Yahoo! Finance
OPK
Earnings
- 10/29/25 - Beat
OPK
Sec Filings
- 11/21/25 - Form 4
- 11/20/25 - Form 4
- 11/19/25 - Form 4
- OPK's page on the SEC website